Age (years) [range] | 57 [33–89] |
---|---|
FIGO stage | |
 IIIA | 52 (32) |
 IIIB | 9 (6) |
 IIIC | 100 (62) |
Histology | |
 Endometrioid | 137 (85) |
 Papillary serous | 16 (10) |
 Clear cell | 5 (3) |
 Mucinous | 2 (1) |
 Neuroendocrine | 1 (1) |
Tumor grade | |
 1 | 52 (32) |
 2 | 57 (36) |
 3 | 52 (32) |
Lymphovascular space invasion | |
 Nil | 42 (26) |
 Present | 119 (74) |
Peritoneal cytology | |
 Negative | 122 (76) |
 Positive | 39 (24) |
Pelvic LN metastasis | |
 Nil | 66 (41) |
 Present |  95 (59) |
 Median number of positive LN [range] | 2 [1–11] |
Para-aortic LN metastasis | |
 Nil | 135 (84) |
 Present |  26 (16) |
 Median number of positive LN [range] | 2 [1–5] |
Total LN metastasis | |
 Nil | 61 (38) |
 Present |  100 (62) |
 Median number of positive LN [range] | 2 [1–12] |